GIS Q2 Deep Dive: Investment in Value and Innovation Amid Volume and Margin Pressures
Is now the time to buy GIS? Find out in our full research report (it's free).
Revenue: $4.56 billion vs analyst estimates of $4.58 billion (3.3% year-on-year decline, 0.5% miss)
Adjusted EPS: $0.74 vs analyst estimates of $0.71 (4.1% beat)
Adjusted EBITDA: $758.1 million vs analyst estimates of $749.6 million (16.6% margin, 1.1% beat)
Operating Margin: 11.1%, down from 16.5% in the same quarter last year
Organic Revenue fell 3% year on year (-6% in the same quarter last year)
Sales Volumes fell 2% year on year, in line with the same quarter last year
Market Capitalization: $27.49 billion
General Mills' second quarter results did not meet Wall Street's sales expectations, with revenue declining year over year—a trend that prompted a significant negative market reaction. Management attributed the underperformance to ongoing volume declines and competitive pressures in core categories, especially within North America Retail. CEO Jeffrey Harmening noted the company's increased focus on value investments in key brands such as Pillsbury and Totino's and expanded efforts in soup, cereal, and fruit snacks. Harmening acknowledged, 'We know that it's an investment year, but we are very confident these investments will pay off given what we've seen over the last couple of quarters.'
Looking ahead, General Mills' strategy centers on driving volume growth through increased marketing, new product launches, and targeted price adjustments, particularly in North America Retail and the pet food segment. Management expects these investments to pressure margins in the near term, but CFO Kofi Bruce explained that some impacts, such as stranded costs from divestitures and tariff-related expenses, are temporary. Harmening emphasized the importance of aligning pricing with competition to enable effective marketing, stating, 'It's about investment and making sure that we get trial on all of our good marketing initiatives.' The company is also betting on innovation, including a national launch of fresh pet food, to return the business to growth.
Management pointed to targeted value investments, stepped-up advertising, and product innovation as central to both recent performance and their plans to restore growth, while acknowledging persistent volume and margin challenges.
Value Investments Expanded: The company increased value-oriented promotions in categories like cereal, soup, and fruit snacks, aiming to improve volume trends. These investments were supported by enhanced advertising, particularly for brands such as Pillsbury and Totino's, which management believes can help regain share lost to competitors.
Fresh Pet Food Launch: General Mills announced a national rollout of Blue Buffalo's refrigerated pet food, building on positive test market results. Management expressed confidence in the brand's ability to scale profitably over time, but cautioned that initial investments to drive consumer trial will weigh on margins for several quarters.
Core Brand Renovations: The company undertook significant product updates and new product introductions, with Harmening describing the 'core renovation news' as the strongest in his tenure. Protein innovation and new seasonal offerings in snacks and cereals are intended to meet evolving consumer preferences.
International and Non-Retail Strength: While North America Retail remains challenged, General Mills reported share gains in international businesses, foodservice, and healthcare channels. These areas provided some offset to domestic headwinds, though management emphasized the need for further growth in its largest categories.
Margin Management and Productivity: Facing input cost pressures and increased reinvestment, management highlighted record levels of holistic margin management (cost-saving initiatives) and ongoing productivity efforts. However, they acknowledged that some margin reductions are temporary, linked to tariffs and stranded costs from divestitures, and expect improvement once these factors abate.
General Mills' outlook is shaped by continued investment in marketing, innovation, and selective pricing actions, with management expecting near-term margin pressure but aiming for volume recovery.
Stepped-Up Marketing and Innovation: Increased advertising spend and the rollout of new products, especially in protein-forward and seasonal segments, are expected to drive trial and brand engagement. Management believes these moves will support volume gains, even if dollar sales lag initially due to price reductions and trade investments.
Margin Headwinds and Recovery: The company anticipates that higher short-term expenses from marketing, tariffs, and stranded costs (such as those related to the Yoplait divestiture) will pressure margins. CFO Kofi Bruce described some of these as 'more temporary in nature,' with expectations for margin improvement as investments scale and cost-saving measures take hold.
Category and Competitive Dynamics: Management does not expect a significant rebound in category growth, instead focusing on competitiveness within core categories. Leadership cited the need to balance volume and pricing, leveraging strategic revenue management tools to navigate inflation, tariffs, and evolving consumer sentiment.
In the next few quarters, our team will be monitoring (1) the volume response to expanded value investments and new product launches, (2) the pace at which margin pressures from tariffs and one-time costs begin to abate, and (3) the national rollout and consumer adoption of Blue Buffalo's fresh pet food line. Execution in core North America Retail categories and the effectiveness of marketing investments will be critical to tracking the company's progress.
General Mills currently trades at $50.72, down from $53.37 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it's free).
Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.
While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
HIMS: Hims & Hers Shares Sink After FTC Probe Details Emerge
Aug 15 - Hims & Hers Health (NYSE:HIMS) slipped about 3% in early trading on Friday after Bloomberg published fresh details about a Federal Trade Commission probe into the company's business practices. The report says the FTC opened an inquiry following consumer complaints that Hims & Hers makes it hard for customers to cancel subscriptions and questions the company's advertising practices. Warning! GuruFocus has detected 4 Warning Sign with HIMS. Hims & Hers first told investors about a regulatory review in July 2024, but Bloomberg's report adds new color on what regulators are investigating. According to people familiar with the matter, the agency looks at cancellation flows, disclosure language, and whether marketing crosses legal lines. The company hasn't released a new statement tied to the Bloomberg story. For investors, the short-term hit reflects the subscription model's vulnerability: when regulators probe cancellation or billing, churn can rise and trust can fall. Analysts will watch complaint volumes, any formal FTC subpoenas, and whether the firm needs to change its renewal mechanics or face penalties. Until that clarity arrives, expect volatility around HIMS shares as traders price regulatory risk into the stock. Based on the one year price targets offered by 13 analysts, the average target price for Hims & Hers Health Inc is $51.22 with a high estimate of $85.00 and a low estimate of $28.00. The average target implies a upside of +8.67% from the current price of $47.13. Based on GuruFocus estimates, the estimated GF Value for Hims & Hers Health Inc in one year is $36.25, suggesting a downside of -23.09% from the current price of $47.13. Gf value is Gurufocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. For deeper insights, visit the forecast page. This article first appeared on GuruFocus. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
7 minutes ago
- Yahoo
Philippe Laffont Loads Up on Oracle, ARM--Cuts AMD, Alibaba, Eli Lilly Stakes
Aug 15 - Philippe Laffont (Trades, Portfolio)'s Coatue shook up its Q2 portfolio, loading into Oracle (ORCL) and ARM (NASDAQ:ARM) while exiting Super Micro (NASDAQ:SMCI) and Monolithic Power (MPWR). The firm bought roughly 3.86 million Oracle shares (about $843.3M) and 4.63 million ARM shares ($749.4M), according to its latest 13F filing, signaling renewed conviction in large-cap cloud and chip plays. Warning! GuruFocus has detected 3 Warning Sign with SMCI. Coatue also increased its stake in CoreWeave (NASDAQ:CRWV) to about 17.8M shares (~$2.9B) and added to positions in Broadcom (AVG) and Nvidia (NASDAQ:NVDA), reflecting a clear tilt toward AI infrastructure. At the same time the hedge fund trimmed holdings in Alibaba (NYSE:BABA), AMD (NASDAQ:AMD) and Eli Lilly (NYSE:LLY), and sold out of Monolithic Power and Super Micro. The moves indicate a change in strategy: strengthen names sensitive to AI compute and cloud capacity and reduce cyclical or less strategic exposure. For investors, the swaps of Coatue are of importance since their bet of more than $0.8B on Oracle reflects its conviction on cloud and software momentum. See what happens to the rest of the large funds; action across the AI related names can exaggerate moves, either upwards when new demand shines through or down when the mood swings. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
37 minutes ago
- Yahoo
Cathie Wood Just Bought 2.5 Million Shares of This IPO Company
Aug 15 - Cathie Wood's Ark Invest just doubled down on one of the market's buzziest new listings. On Wednesday Ark bought more than 2.5 million shares of Bullish (NYSE:BLSH), spreading the purchase across three active ETFs: ARK Innovation (ARKK) picked up about 1.74 million shares, ARK Next Generation Internet (ARKW) added 545,416 shares, and ARK Fintech Innovation (ARKF) took 272,755 shares. Warning! GuruFocus has detected 5 Warning Sign with UNH. Bullish, the crypto exchange backed by Peter Thiel, exploded on its first trading day, jumping roughly 84%, and then climbed another 15% the following session as traders piled in. Wood's move signals she wants bigger exposure to crypto infrastructure, and it complements Ark's existing holdings in Coinbase (COIN) and the ARK 21Shares Bitcoin ETF (ARKB). Beyond trading, Bullish also owns CoinDesk, giving Ark both a trading-platform stake and media exposure to crypto audiences. The trade reflects confidence in digital-asset adoption despite ongoing regulatory scrutiny. If crypto gets another hot streak, Ark's latest purchases could prove prescient. If regulators tighten, the same stake could face pressure, but for now, Wood appears to be banking on momentum and long-term upside in crypto infrastructure. This article first appeared on GuruFocus. Sign in to access your portfolio